Biosimilars Archives

News and Trends 10 Oct 2015

What Happened this Week? Nobel prize slips through CRISPR’s fingers, inside iGEM’s Jamboree and €120M boost for Alzheimer’s research

Monday: Manfred Horst on MSD, Biosimilars, KEYTRUDA and Merck & Co.’s rich history Tuesday: An Insider’s experience at the iGEM Giant Boston Jamboree 2015 Wednesday: Sorry CRISPR, you’ll have to wait another year to win a Nobel Prize! Thursday: The Future Biotech Lab Bench: My experience of the cutting edge-tech at LABVOLUTION Friday: Alzheimer’s Disease: Phase III breakthrough Tau-therapy earns […]

October 10, 2015 - 1 minutemin - By Philip Hemme

News and Trends 5 Oct 2015

Manfred Horst on MSD, Biosimilars, KEYTRUDA and his Company’s rich history

Manfred Horst is a Director Business Development Europe and working from an office at MSD France, the French affiliate of MSD which has its HQ in New Jersey (and is known as Merck & Co. in the US). MSD is one of the biggest pharmaceutical companies in the world with a 2014 revenue of €37.4Bn and €6.4Bn […]

October 5, 2015 - 6 minutesmins - By Julie Lellouche

News and Trends 25 Sep 2015

Roche’s patent halts an Amgen biosimilar debut

Amgen has had great success with its Avastin biosimilar, used as an inhibitor of angiogenesis in tumor growth. However, despite smashing the phase III trials, the Amgen-Allergan partnership still has to wait until 2022 for Roche’s European Avastin patent to expire. Amgen partnered up with Dublin based Allergan (Ireland) for a comprehensive oncology biosimilars pipeline […]

September 25, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 8 Jun 2015

Biosimilars will land in Poland thanks to a European loan

Biosimilars will have their Polish guarantor. Polpharma, the largest Polish producer of medicines, is the first benefactor of a €45M loan granted by the European Investment Bank. The loan was granted for research and development of biosimilars and is part of InnovFin, the EU fund for innovators. The production of biosimilars involves numerous difficulties in […]

June 8, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 7 May 2015

Is the Biotech sector facing the issues of the Pharma Industry?

Currently, the pharma industry is going through a serious crisis, as the sector needs to review its economic model. On the other hand, the biotech sector often considered as the best way to innovate seems less promising than expected when it comes to putting drugs up on the market. Knowing this, it is likely that the biotech industry will face […]

May 7, 2015 - 5 minutesmins - By Nicolas Sainte-Foie

News and Trends 28 Apr 2015

Will 2015 be the year of biosimilars?

The Biosimilar drug field is growing fast despite the tight regulatory, business and financial challenges it faces. The industry is forecasted to be worth up to €23Bn by 2020. To explore the market opportunities for biosimilars, it is necessary to be aware of all the latest news and to stand at the forefront of the current landscape […]

April 28, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 6 Mar 2015

Novartis achieves the First Biosimilar approval in US

The Novartis company Sandoz has become the first company with a biosimilar approved by the US Food and Drug Administration (FDA) after today’s approval of Zarxio, a treatment for neutropenia. Sandoz is the first company to receive the approval of a biosimilar in the US through the new FDA biosimilars pathway established under Biologics Price […]

March 6, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 26 Feb 2015

Celltrion launches world’s first biosimilar monoclonal antibody in 12 new European markets

Celltrion Healthcare has today announced the launch of Remsima (infliximab) in 12 European markets: Austria, Belgium, Denmark, France, Germany, Greece, Italy, Luxembourg, the Netherlands, Spain, Sweden and the UK. The treatment to the treatment of autoimmune diseases is now available in 31 countries. Remsima, developed by the South Korean company Celltrion, is the world’s first biosimilar monoclonal […]

February 26, 2015 - 2 minutesmins - By Lourdes Riquelme

Eli Lilly and Boehringer Ingelheim’s product the first insulin biosimilar approved in Europe2

News and Trends 16 Sep 2014

The first insulin biosimilar has been approved in Europe

The European Commission granted marketing authorisation to Eli Lilly and Company and Boehringer Ingelheim for the first insulin biosimilar glargine product. It is indicated to treat diabetes in adults, adolescents and children aged 2 years and above. The collaboration between the two companies is bearing fruit, it is the first-ever version of this class. It received […]

September 16, 2014 - 2 minutesmins - By Julie Lellouche

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Biosimilars

What Happened this Week? Nobel prize slips through CRISPR’s fingers, inside iGEM’s Jamboree and €120M boost for Alzheimer’s research

Manfred Horst on MSD, Biosimilars, KEYTRUDA and his Company’s rich history

Roche’s patent halts an Amgen biosimilar debut

Biosimilars will land in Poland thanks to a European loan

Is the Biotech sector facing the issues of the Pharma Industry?

Will 2015 be the year of biosimilars?

Novartis achieves the First Biosimilar approval in US

Celltrion launches world’s first biosimilar monoclonal antibody in 12 new European markets

The first insulin biosimilar has been approved in Europe

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!